Having successfully launched one of the first funds operating in the nascent psychedelic medicine space, Toronto-based venture capital firm Noetic is now launching a second, larger Fund. TORONTO, ON / ACCESSWIRE / March 4, 2021 / The “Noetic Funds,” founded by the team at Grey House Partners GP Inc., has announced the launch of Noetic Fund II LP (“Fund II”), a venture capital fund that is seeking…


Previous articleTryp Therapeutics Announces Application to List on OTCQB
Next articleMEC Signs RTO Definitive Agreement To Acquire Albert Labs, A European Psychedelic Drug Researcher & Developer